Rohit Vanjani

Stock Analyst

(n/a)

# 4,425

Out of 4,433 analysts

6

Total ratings

n/a

Success rate

n/a

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - Specialty & Generic Biotechnology

3 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	RVNC Revance Therapeutics	Upgrades: Buy	n/a	$3.02	-	3	Nov 16, 2018
	DERM Journey Medical	Downgrades: Neutral	n/a	$3.45	-	2	Mar 6, 2018
	TEVA Teva Pharmaceutical	Initiates: Neutral	n/a	$16.29	-	1	Dec 12, 2017

Revance Therapeutics

Nov 16, 2018

Upgrades: Buy

Price Target: n/a

Current: $3.02

Upside: -

Journey Medical

Mar 6, 2018

Downgrades: Neutral

Price Target: n/a

Current: $3.45

Upside: -

Teva Pharmaceutical

Dec 12, 2017

Initiates: Neutral

Price Target: n/a

Current: $16.29

Upside: -